Photo from wikipedia
Growing studies have demonstrated clinical benefits of fecal microbiota transplantation (FMT) therapy (administered by colonoscopy, enema, or both) for active ulcerative colitis (UC). This study aimed to evaluate the cost‐effectiveness… Click to show full abstract
Growing studies have demonstrated clinical benefits of fecal microbiota transplantation (FMT) therapy (administered by colonoscopy, enema, or both) for active ulcerative colitis (UC). This study aimed to evaluate the cost‐effectiveness of standard treatment with and without FMT therapy for mild‐to‐moderate active UC from the perspective of US healthcare provider.
Keywords:
microbiota transplantation;
fecal microbiota;
active ulcerative;
ulcerative colitis;
cost effectiveness
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!